Posted by Michael Wonder on 22 Sep 2020
Knight and TherapeuticsMD announce Health Canada approval of Bijuva
21 September 2020 - Knight Therapeutics and TherapeuticsMD announced today the approval of Bijuva (estradiol and progesterone) capsules by Health Canada.
In Canada, Bijuva is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause in women with an intact uterus.
Vasomotor symptoms are commonly known as hot flashes or flushes and night sweats.
